From AUA: ADJUVANT VS. SALVAGE RADIATION THERAPY For Prostate Cancer
On Sunday at the AUA conference there was a poster (#159) titled ADJUVANT VS. SALVAGE RADIATION THERAPY FOLLOWING PROSTATECTOMY FOR LOCALLY ADVANCED PROSTATE CANCER: RESULTS FROM SEER-MEDICARE written by Keith J. Kowalczyk, etal. The researchers [...]
From the AUA – Treated Positive Surgical Margins Impact Survival
Currently the American Urologic Association is holding their annual conference. Like the ASCO and AACR conferences there are many presentations and posters given that harkens the latest in research findings for general urological topics as [...]
The Role of Hope and Faith In Fighting Prostate Cancer
You are sitting in your doctor’s office listening to the doctor tell you that you have prostate cancer! Immediately, numbness and disbelief creep into your reality. Over time, the news sinks in and you begin [...]
Where Are The Prostate Cancer Mets Located?
Sometimes I have heard the question, Where can prostate cancer metastasis (met) be found? Usually, the question really means, how can my met in my spleen or liver (or what ever) come from my prostate [...]
Announcing A Phase 2 Clinical Trial of MDV3100 in Hormone-Naive Prostate Cancer Patients
For our European readers who have not yet started, but are getting ready to start hormone deprivation therapy (ADT), there is a new clinical trial you should consider. This trial is evaluating MDV3100 monotherapy as [...]
New Approved Drugs Keep Us in the Proverbial Pickle
Over the last year or so we have seen a marked change in the treatment landscape for men with castrate resistant advanced prostate cancer. The FDA has approved sipuleucel-T (Provenge), cabazitaxel (Jevtana) and last week [...]